Advanced BioMedical Technologies, Inc.
ABMT
$0.0002
-$0.0004-66.67%
| Weiss Ratings | ABMT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | ABMT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | ABMT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.99 | |||
| Price History | ABMT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -66.67% | |||
| 30-Day Total Return | -66.67% | |||
| 60-Day Total Return | -66.67% | |||
| 90-Day Total Return | -66.67% | |||
| Year to Date Total Return | -66.67% | |||
| 1-Year Total Return | -66.67% | |||
| 2-Year Total Return | -99.60% | |||
| 3-Year Total Return | -99.71% | |||
| 5-Year Total Return | -99.89% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | ABMT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Apr 29, 2024 | |||
| 52-Week High Price (Date) | Apr 29, 2024 | |||
| Valuation | ABMT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 42.54K | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | 57.35% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.40 | |||
| Price/Book (Q) | -0.01 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ABMT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 70.46M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ABMT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 718 766 7898 | |||
| Address | 200 Park Avenue New York, NY 10166 | |||
| Website | abtlafleur.com | |||
| Country | United States | |||
| Year Founded | 2002 | |||
| Profitability | ABMT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -385.97% | |||
| Profit Margin | -685.88% | |||
| Management Effectiveness | ABMT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -78.12% | |||
| Return on Equity | -- | |||
| Income Statement | ABMT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 109.80K | |||
| Total Revenue (TTM) | 109.80K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 81.70K | |||
| EBITDA (TTM) | -408.90K | |||
| EBIT (TTM) | -423.80K | |||
| Net Income (TTM) | -753.10K | |||
| Net Income Avl. to Common (TTM) | -753.10K | |||
| Total Revenue Growth (Q YOY) | -80.00% | |||
| Earnings Growth (Q YOY) | 3.17% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 3.45% | |||
| Balance Sheet | ABMT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 7.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 242.60K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -8.18M | |||
| Current Ratio (Q) | 0.028 | |||
| Book Value Per Share (Q) | -$0.12 | |||
| Total Assets (Q) | 396.50K | |||
| Total Current Liabilities (Q) | 8.58M | |||
| Total Debt (Q) | 6.36M | |||
| Total Liabilities (Q) | 8.58M | |||
| Total Common Equity (Q) | -8.18M | |||
| Cash Flow | ABMT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -52.50K | |||
| Cash from Financing (TTM) | 21.90K | |||
| Net Change in Cash (TTM) | -7.50K | |||
| Levered Free Cash Flow (TTM) | 396.00K | |||
| Cash from Operations (TTM) | 9.10K | |||
